
Northwell Ventures
Description
Northwell Ventures serves as the corporate venture arm of Northwell Health, one of the largest healthcare providers in the United States. Established to foster innovation and strategic growth, its primary mission is to invest in early-stage companies that align with Northwell Health's strategic priorities, aiming to advance medical technology and enhance healthcare delivery. The venture arm plays a crucial role in identifying and nurturing promising startups that can bring transformative solutions to the healthcare landscape, leveraging Northwell's extensive clinical expertise and operational insights.
The investment focus of Northwell Ventures spans critical areas within healthcare, including digital health, medical devices, diagnostics, and therapeutics. Beyond providing capital, Northwell Ventures emphasizes strategic partnerships, offering portfolio companies access to Northwell Health's vast network, clinical trials, and real-world testing environments. This collaborative approach helps accelerate product development, validation, and market adoption, ensuring that innovative solutions are effectively integrated into patient care pathways and health system operations.
Northwell Ventures typically participates in early-stage funding rounds, including Seed, Series A, and Series B. Their initial investment checks have historically ranged from $1 million to $5 million, providing substantial support to emerging companies. As of a 2021 report, the venture arm had already made investments in approximately 10 companies, demonstrating a focused yet active portfolio. These investments are driven by a dual mandate: to generate financial returns and, more importantly, to integrate cutting-edge technologies and solutions that can improve patient outcomes, reduce costs, and enhance the overall efficiency of healthcare services.
Investor Profile
Northwell Ventures has backed more than 21 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 43% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, Singapore, Ireland.
- Strong thematic focus on Health Care, Medical, Software.
- Led 1 rounds in the past year.
- Typical check size: $1M – $5M.
Stage Focus
- Series Unknown (38%)
- Series B (29%)
- Series A (14%)
- Seed (14%)
- Series C (5%)
Country Focus
- United States (86%)
- Singapore (10%)
- Ireland (5%)
Industry Focus
- Health Care
- Medical
- Software
- Electronic Health Record (Ehr)
- Mhealth
- Biotechnology
- Medical Device
- Information Technology
- Artificial Intelligence (Ai)
- Hospital
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.